NO953877L - Fosfonometyldipeptider - Google Patents

Fosfonometyldipeptider

Info

Publication number
NO953877L
NO953877L NO953877A NO953877A NO953877L NO 953877 L NO953877 L NO 953877L NO 953877 A NO953877 A NO 953877A NO 953877 A NO953877 A NO 953877A NO 953877 L NO953877 L NO 953877L
Authority
NO
Norway
Prior art keywords
alkyl
hydrogen
aryl
nothing
cycloalkyl
Prior art date
Application number
NO953877A
Other languages
English (en)
Norwegian (no)
Other versions
NO953877D0 (no
Inventor
Orchymont Hugues D
Marc Bigaud
Original Assignee
Merrell Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Pharma Inc filed Critical Merrell Pharma Inc
Publication of NO953877D0 publication Critical patent/NO953877D0/no
Publication of NO953877L publication Critical patent/NO953877L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Neurology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
NO953877A 1993-03-30 1995-09-29 Fosfonometyldipeptider NO953877L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP93400824A EP0618224A1 (en) 1993-03-30 1993-03-30 Phosphonomethyldipeptides
PCT/US1994/001716 WO1994022908A1 (en) 1993-03-30 1994-02-22 Phosphonomethyldipeptides

Publications (2)

Publication Number Publication Date
NO953877D0 NO953877D0 (no) 1995-09-29
NO953877L true NO953877L (no) 1995-11-30

Family

ID=8214693

Family Applications (1)

Application Number Title Priority Date Filing Date
NO953877A NO953877L (no) 1993-03-30 1995-09-29 Fosfonometyldipeptider

Country Status (20)

Country Link
EP (2) EP0618224A1 (da)
JP (1) JP3541230B2 (da)
KR (1) KR100311852B1 (da)
CN (1) CN1120844A (da)
AT (1) ATE192456T1 (da)
AU (1) AU670866B2 (da)
CA (1) CA2156742C (da)
DE (1) DE69424281T2 (da)
DK (1) DK0691985T3 (da)
ES (1) ES2148322T3 (da)
FI (1) FI954656A0 (da)
GR (1) GR3034015T3 (da)
HU (1) HU217836B (da)
IL (1) IL109128A (da)
NO (1) NO953877L (da)
NZ (1) NZ262996A (da)
PT (1) PT691985E (da)
TW (1) TW290550B (da)
WO (1) WO1994022908A1 (da)
ZA (1) ZA942091B (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5583123A (en) * 1994-12-22 1996-12-10 Ciba-Geigy Corporation Certain tetrazole derivatives
US5550119A (en) * 1995-03-02 1996-08-27 Ciba-Geigy Corporation Phosphono substituted tetrazole derivatives as ECE inhibitors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8726714D0 (en) * 1987-11-14 1987-12-16 Beecham Group Plc Compounds
JP2811608B2 (ja) * 1991-04-26 1998-10-15 日本ケミファ株式会社 ホスホン酸アミド誘導体およびエンドセリン変換酵素阻害剤
JPH05105698A (ja) * 1991-06-13 1993-04-27 Takeda Chem Ind Ltd ホスホン酸誘導体、その製造法および用途

Also Published As

Publication number Publication date
CA2156742A1 (en) 1994-10-13
IL109128A0 (en) 1994-06-24
HU217836B (hu) 2000-04-28
JPH08508480A (ja) 1996-09-10
KR960701088A (ko) 1996-02-24
WO1994022908A1 (en) 1994-10-13
ATE192456T1 (de) 2000-05-15
AU6298994A (en) 1994-10-24
CA2156742C (en) 2001-04-17
AU670866B2 (en) 1996-08-01
EP0691985A1 (en) 1996-01-17
HUT72465A (en) 1996-04-29
NZ262996A (en) 1996-06-25
EP0691985B1 (en) 2000-05-03
CN1120844A (zh) 1996-04-17
DK0691985T3 (da) 2000-08-07
JP3541230B2 (ja) 2004-07-07
NO953877D0 (no) 1995-09-29
DE69424281D1 (en) 2000-06-08
PT691985E (pt) 2000-08-31
IL109128A (en) 1999-09-22
FI954656L (fi) 1995-09-29
GR3034015T3 (en) 2000-11-30
HU9502852D0 (en) 1995-11-28
KR100311852B1 (ko) 2002-02-28
FI954656A7 (fi) 1995-09-29
ZA942091B (en) 1994-10-24
FI954656A0 (fi) 1995-09-29
ES2148322T3 (es) 2000-10-16
DE69424281T2 (de) 2000-09-21
TW290550B (da) 1996-11-11
EP0618224A1 (en) 1994-10-05

Similar Documents

Publication Publication Date Title
NO922851L (no) Trifluormetylbenzylfosfonater som er nyttig for behandling av osteporose
NO954427L (no) Hiv-proteaseinhibitorer som er anvendbare for behandling av AIDS
LU91069I2 (fr) Aprepitant et ses sels pharmaceutiquement acceptables (EMEND)
IL129724A0 (en) Crystals of benzimidazole derivatives and their production
NO943093L (no) Fremgangsmåte for fremstilling av clavulansyre
YU142188A (en) Process for preparing polyethylenglycolcarbaminates
DE69133299D1 (de) Aminosulfonylcarbamate
MX9701325A (es) Metodos para inhibir la mucositis ulcerativa.
MX9701329A (es) Metodos para la inhibicion de la replicacion viral.
NO911041L (no) Fremgangsmaate for fremstilling av 3-tetrazolyltiometyl-cefalosporinantibiotika.
NO832923L (no) Fremgangsmaate for fremstilling av farmasoeytisk aktive 4-(3-trifluormetylfenyl)-1,2,3,6-tetrahydropyridin-derivater
ZA908285B (en) 3-aryloxazolidinone derivatives,process for their preparation and their use in therapy
DK0652004T3 (da) Fremgangsmåder til behandling af resistente neoplasmer
IL90792A0 (en) Piperidine derivatives
NO932431L (no) Fremgangsmaate og mellomprodukter for fremstilling av azabicyklo(2,2,2)oktan-3-iminer
NO953877L (no) Fosfonometyldipeptider
EA199800019A1 (ru) Способ повышения плотности кальциевых каналов
HUT51603A (en) Herbicide and plant growth regulating preparation containing alkyl- and alkenyl-sulfonyl-urea compounds substituted by heterocyclic radical as well as process for producing the active agents
NO982927L (no) Biologisk aktive benzotiazolon etanaminer
EA199800366A1 (ru) Способы ингибирования ингибитора 1 активатора плазминогена
NO944513L (no) Oksadiazolderivater, fremgangsmåte for deres fremstilling og anvendelse
NO159018C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive disubstituerte polymetyleniminer.
AR247737A1 (es) Un procedimiento para la fabricacion de compuestos.
PT76004A (en) Process for preparing novel pyrimidine derivatives useful in treating peptic ulcers
NO934227L (no) Pyrrolderivater, fremgangsmåte for deres fremstilling og terapeutiske anvendelse